It cannot be cardiac failure because the heart is not enlarged on the chest x-ray

European Journal of Heart Failure

Volumn 5, Issue 2, 2003, Pages 117-119

  Petrie, Mark C ^a   McMurray, John J V ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; RADIOISOTOPE;

CARDIOMEGALY; CLINICAL TRIAL; ECHOCARDIOGRAPHY; EDITORIAL; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE FUNCTION; HEART SIZE; HUMAN; MORTALITY; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

CARDIOMEGALY; CLINICAL TRIALS; DISEASE PROGRESSION; HEART; HEART FAILURE, CONGESTIVE; HUMANS; RADIOGRAPHIC IMAGE ENHANCEMENT; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037352139     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00239-8     Document Type: Editorial

References (28)

1. Davidson C. Can heart failure be diagnosed in primary care? Chest radiography is still useful. Br Med J. 2000;321:1414.
2. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen-consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87:5-6.
3. Loeb HS, Johnson G, Henrick A, et al. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. Circulation 1993;87:78-87.
4. Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure - the V-HeFT studies. Circulation 1993;87:102-10.
5. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-10.
6. Uretsky BF, Young JB, Shahidi FE, et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure - results of the PROVED trial. Am Coll Cardiol. 1993;22:955-62.
7. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med. 1993;329:1-7.
8. Abernathy GT, Abrams J, Akhtar S, et al. Rationale, design, implementation, and baseline characteristics of patients in the DIG trail: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Controlled Clin Trials 1996;17:77-97.
9. Perry G, Brown E, Thornton R, et al. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-33.
10. Philbin EF, Garg R, Danisa K, et al. The relationship between cardiothoracic ratio and left ventricular ejection fraction in congestive heart failure. Arch Int Med. 1998;158:501-6.
11. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Eng J Med. 1996;335:1107-14.
12. Hampton JR, vanVeldhuisen DJ, Kleber FX, et al. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet 1997;349:971-7.
13. Nicklas JM, Pitt B, Timmis G, et al. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Eng J Med. 1992;327:685-91.
14. Bangdiwala SI, Weiner DH, Bourassa MG, et al. Studies of left ventricular dysfunction (SOLVD) registry - rationale, design, methods and description of baseline characteristics. Am J Cardiol. 1992;70:347-53.
15. Johnstone D, Limacher M, Rousseau M, et al. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol. 1992;70:894-900.
16. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure-a report from the registry of studies of left ventricular dysfunction (SOLVD). South Med J. 1995;88:514-23.
17. Yusuf S. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
18. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med. 1991;325:1468-75.
19. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med. 1998;339:1810-6.
20. Clark AL, Coats AJ. Unreliability of cardiothoracic ratio as a marker of left ventricular impairment: comparison with radionuclide ventriculography and echocardiography. Postgrad Med J. 2000;76:289-91.
21. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-55.
22. Lechat P, Brunhuber KW, Hofmann R, et al. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomised trial. Lancet 1999;353:9-13.
23. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effect of metoprolol CR XL in chronic heart failure: metoprolol CR XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
24. Rihal CS, Davis KB, Kennedy JW, et al. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol. 1995;75:220-3.
25. Davie AP, Francis CM, Love MP, et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. Br Med J. 1996;312:222.
26. Pirwitz MJ, Lange RA, Landau C, et al. Utility of the 12-lead electrocardiogram in identifying underlying coronary artery disease in patients with depressed left ventricular systolic function. Am J Cardiol. 1996;77:1289-92.
27. Christian TF, Miller TD, Chareonthaitawee P, et al. Prevalence of normal resting left ventricular function with normal rest electrocardiograms. Am J Cardiol. 1997;79:1295-300.
28. Kleber FX, Niemoller L, Fischer M, et al. Influence of severity of heart failure on the efficacy of angiotensin converting enzyme inhibition. Am J Cardiol. 1991;68:D121-6.